Select Page

European University Cyprus and Europa Uomo Cyprus sign Memorandum of Understanding for the Support of Patients with Prostate Cancer

Posted: November 19, 2019

A Memorandum of Understanding on issues relating to awareness, early diagnosis and the support of patients with male cancer and particularly prostate cancer, was signed on 15 November between European University Cyprus and Europa Uomo Cyprus. The memorandum was signed on behalf of the University by the Vice-Rector for Research and Foreign Affairs, Professor Andreas Efstathiou, and on behalf of Europa Uomo Cyprus, by the president of the association Mr. Andreas Moisseos.

It is noted that the signing of the Memorandum recognizes the need to support patients with prostate cancer in order to ensure effective management through European reference networks. The Memorandum of Understanding contains the important provision concerning the promotion of national benefits in the management of holistic care of patients with prostate cancer.

At the same time, the Memorandum provides inter alia the briefing of patients regarding procedures for the provision of services to persons with prostate cancer, particularly on European treatment protocols through cross-border healthcare.

Speaking at the signing ceremony, Vice-Rector Efstathiou acknowledged the important role that Europa Uomo Cyprus has played in the last twelve years of its existence, in providing information on early diagnosis and prevention of male cancer. The signing of the Memorandum of Understanding further strengthens its efforts, drawing on the know-how of European University Cyprus, he added.

President of Europa Uomo Cyprus, Andreas Moisseos, thanked the Vice-Rector and the Professors of European University Cyprus for their cooperation, which will help with the organisation of medical conferences at the University for both students and the public.

European University Cyprus and Europa Uomo Cyprus are organizing on Tuesday, 19 November 2019 at 17:00-20:00 an event (Amphitheatre Beta) on ‘Prostate Cancer’. Admission to the public is free.